Free Trial

Owlet (OWLT) Competitors

Owlet logo
$4.95 -0.30 (-5.77%)
Closing price 03:58 PM Eastern
Extended Trading
$4.94 0.00 (-0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OWLT vs. FEIM, CTKB, OPTX, LAB, and NAUT

Should you buy Owlet stock or one of its competitors? MarketBeat compares Owlet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Owlet include Frequency Electronics (FEIM), Cytek Biosciences (CTKB), Syntec Optics (OPTX), Standard BioTools (LAB), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry.

How does Owlet compare to Frequency Electronics?

Owlet (NYSE:OWLT) and Frequency Electronics (NASDAQ:FEIM) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk.

72.6% of Owlet shares are owned by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are owned by institutional investors. 52.2% of Owlet shares are owned by insiders. Comparatively, 28.0% of Frequency Electronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Owlet presently has a consensus target price of $20.00, suggesting a potential upside of 304.29%. Frequency Electronics has a consensus target price of $43.67, suggesting a potential downside of 36.86%. Given Owlet's higher possible upside, analysts plainly believe Owlet is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

Frequency Electronics has a net margin of 10.78% compared to Owlet's net margin of -42.54%. Frequency Electronics' return on equity of 12.69% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Frequency Electronics 10.78%12.69%7.84%

Frequency Electronics has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.36-$39.68M-$3.07N/A
Frequency Electronics$69.81M9.75$23.69M$0.7592.21

Owlet has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, Frequency Electronics has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

In the previous week, Frequency Electronics had 3 more articles in the media than Owlet. MarketBeat recorded 3 mentions for Frequency Electronics and 0 mentions for Owlet. Frequency Electronics' average media sentiment score of 0.99 beat Owlet's score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Frequency Electronics Positive

Summary

Frequency Electronics beats Owlet on 11 of the 17 factors compared between the two stocks.

How does Owlet compare to Cytek Biosciences?

Owlet (NYSE:OWLT) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Owlet presently has a consensus price target of $20.00, indicating a potential upside of 304.29%. Cytek Biosciences has a consensus price target of $5.69, indicating a potential upside of 40.43%. Given Owlet's stronger consensus rating and higher possible upside, analysts clearly believe Owlet is more favorable than Cytek Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

72.6% of Owlet shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 52.2% of Owlet shares are held by company insiders. Comparatively, 10.4% of Cytek Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Owlet has a beta of 1.85, suggesting that its share price is 85% more volatile than the broader market. Comparatively, Cytek Biosciences has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Cytek Biosciences has a net margin of -36.25% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Cytek Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Cytek Biosciences -36.25%-10.07%-7.56%

Owlet has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.36-$39.68M-$3.07N/A
Cytek Biosciences$201.49M2.60-$66.54M-$0.57N/A

In the previous week, Cytek Biosciences had 4 more articles in the media than Owlet. MarketBeat recorded 4 mentions for Cytek Biosciences and 0 mentions for Owlet. Cytek Biosciences' average media sentiment score of 0.30 beat Owlet's score of 0.00 indicating that Cytek Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Cytek Biosciences Neutral

Summary

Owlet beats Cytek Biosciences on 8 of the 15 factors compared between the two stocks.

How does Owlet compare to Syntec Optics?

Owlet (NYSE:OWLT) and Syntec Optics (NASDAQ:OPTX) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Syntec Optics has a net margin of -10.95% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Syntec Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Syntec Optics -10.95%-30.86%-12.35%

Owlet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, Syntec Optics has a beta of -0.82, suggesting that its stock price is 182% less volatile than the broader market.

In the previous week, Syntec Optics had 2 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Syntec Optics and 0 mentions for Owlet. Syntec Optics' average media sentiment score of 0.94 beat Owlet's score of 0.00 indicating that Syntec Optics is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Syntec Optics Positive

72.6% of Owlet shares are owned by institutional investors. 52.2% of Owlet shares are owned by company insiders. Comparatively, 0.8% of Syntec Optics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Owlet presently has a consensus price target of $20.00, suggesting a potential upside of 304.29%. Given Owlet's stronger consensus rating and higher possible upside, equities analysts plainly believe Owlet is more favorable than Syntec Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Syntec Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Syntec Optics has lower revenue, but higher earnings than Owlet. Syntec Optics is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.36-$39.68M-$3.07N/A
Syntec Optics$28.08M18.12-$1.79M-$0.08N/A

Summary

Owlet beats Syntec Optics on 9 of the 16 factors compared between the two stocks.

How does Owlet compare to Standard BioTools?

Owlet (NYSE:OWLT) and Standard BioTools (NASDAQ:LAB) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

Owlet has higher revenue and earnings than Standard BioTools. Owlet is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.36-$39.68M-$3.07N/A
Standard BioTools$85.33M5.22-$74.90M$0.205.70

Owlet currently has a consensus target price of $20.00, suggesting a potential upside of 304.29%. Standard BioTools has a consensus target price of $1.35, suggesting a potential upside of 18.42%. Given Owlet's stronger consensus rating and higher possible upside, equities analysts plainly believe Owlet is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Standard BioTools has a net margin of 73.46% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Standard BioTools' return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Standard BioTools 73.46%-8.18%-6.43%

72.6% of Owlet shares are owned by institutional investors. Comparatively, 53.7% of Standard BioTools shares are owned by institutional investors. 52.2% of Owlet shares are owned by insiders. Comparatively, 26.8% of Standard BioTools shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Standard BioTools had 1 more articles in the media than Owlet. MarketBeat recorded 1 mentions for Standard BioTools and 0 mentions for Owlet. Standard BioTools' average media sentiment score of 0.93 beat Owlet's score of 0.00 indicating that Standard BioTools is being referred to more favorably in the news media.

Company Overall Sentiment
Owlet Neutral
Standard BioTools Positive

Owlet has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, Standard BioTools has a beta of 1.39, meaning that its share price is 39% more volatile than the broader market.

Summary

Owlet beats Standard BioTools on 9 of the 16 factors compared between the two stocks.

How does Owlet compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Owlet (NYSE:OWLT) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

In the previous week, Nautilus Biotechnology had 2 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Nautilus Biotechnology and 0 mentions for Owlet. Nautilus Biotechnology's average media sentiment score of 0.94 beat Owlet's score of 0.00 indicating that Nautilus Biotechnology is being referred to more favorably in the media.

Company Overall Sentiment
Nautilus Biotechnology Positive
Owlet Neutral

50.7% of Nautilus Biotechnology shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 41.1% of Nautilus Biotechnology shares are owned by insiders. Comparatively, 52.2% of Owlet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Owlet has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nautilus BiotechnologyN/AN/A-$59M-$0.46N/A
Owlet$105.70M1.36-$39.68M-$3.07N/A

Nautilus Biotechnology has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Owlet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market.

Nautilus Biotechnology has a net margin of 0.00% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Nautilus Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nautilus BiotechnologyN/A -35.04% -29.16%
Owlet -42.54%N/A -18.02%

Nautilus Biotechnology currently has a consensus price target of $4.00, indicating a potential upside of 55.04%. Owlet has a consensus price target of $20.00, indicating a potential upside of 304.29%. Given Owlet's stronger consensus rating and higher possible upside, analysts clearly believe Owlet is more favorable than Nautilus Biotechnology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Owlet beats Nautilus Biotechnology on 11 of the 15 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OWLT vs. The Competition

MetricOwletTechnology Services IndustryBusiness SectorNYSE Exchange
Market Cap$152.26M$4.31B$6.65B$23.28B
Dividend YieldN/A2.00%2.99%4.06%
P/E Ratio-1.6146.4129.2631.00
Price / Sales1.3650.55412.1223.82
Price / CashN/A43.2524.9124.93
Price / Book6.974.955.904.67
Net Income-$39.68M$31.69M$203.88M$1.07B
7 Day Performance-13.21%0.76%1.03%-0.67%
1 Month Performance2.63%0.35%1.38%0.22%
1 Year Performance-17.27%37.64%40.54%25.44%

Owlet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OWLT
Owlet
2.6962 of 5 stars
$4.95
-5.8%
$20.00
+304.3%
-15.2%$152.26M$105.70MN/A106
FEIM
Frequency Electronics
1.5488 of 5 stars
$68.56
+0.8%
$43.67
-36.3%
+295.2%$669.35M$69.81M91.41200
CTKB
Cytek Biosciences
2.7628 of 5 stars
$3.97
-1.0%
$5.69
+43.3%
+48.1%$517.86M$201.49MN/A500
OPTX
Syntec Optics
0.6126 of 5 stars
$11.42
+6.9%
N/A+732.1%$430.19M$28.08MN/A3
LAB
Standard BioTools
2.1249 of 5 stars
$1.09
+5.8%
$1.35
+23.9%
+10.5%$402.08M$85.33M5.45620

Related Companies and Tools


This page (NYSE:OWLT) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners